Happyily  Ever  After  -  From Biohacking pregnant


Research|Social Innovation | Speculative Design


Personal  Project

( 2023. London )


The project explores the relationship between economic privilege and healthy life expectancy inequality in the biohacking space.

Happily, After ever, a biohacking startup company, has launched a product to extend the life span of a new life in 2030. It enables pregnant mothers to control the cord blood by inserting money into the cord blood to reduce the pregnancy time of their babies and "extend the life span" of their children at the beginning of life. This is a design prediction based on the reality of economic privilege and life expectancy inequality for the future of the biohacking commodity market, biohacking products as a provocative design tool to establish a connection with this gray space.

In 2023, the global gap between rich and poor and health inequalities widened further, with London, for example, one street away, having a ten-year difference in life expectancy. In the unregulated and lawless biohacking space, the economically privileged try to exchange young blood to enhance their economic privilege; The ill-fated use the cheapest but riskiest generic drugs to save lives. When health is measured by money, who exactly is biohacking - this popular "citizen science movement" - offering secular salvation?